Table 2.

Sample Characteristics stratified by trial participation

	Total		Non Trial		Trial
	N (738)	%	N (514)	%	N (224)	%
Demographic and Behavioral Characteristics
Age (years)
<40	429	58.1	300	58.4	129	57.6
Gender/sexual preference
MSM1/Bisexual men	252	34.2	160	31.1	92	41.1*
Heterosexual men	260	35.2	183	35.6	77	34.4
Heterosexual women	226	30.6	171	33.3	55	24.6
Race
Black	455	61.7	337	65.6	118	52.7**
Access to Care Characteristics
Insurance Status
Public2	191	25.9	162	31.5	29	13.0**
None	276	37.4	176	34.2	100	44.6
Private/Other	258	35.0	170	33.1	88	39.3
Distance to ID3 clinic (miles)
<50	182	24.7	123	23.9	59	36.3
>50	527	71.4	390	75.8	137	61.2
Clinical Characteristics
CD4 cells/uL
≤200	321	43.5	200	38.9	121	54*
>200	246	33,5	176	34.2	70	31.3
Mean HIV RNA (log10) (sd)	4.7	(1.0)	4.7	(0.95)	4.7	(1.03)
Diagnosis to treatment (months)
≤3	250	33.9	195	37.9	55	24.6
>3	393	53.3	289	56.2	104	46.4
Other Laboratory Parameters
ANC4 (109/L)
Normal	348	47.2	223	43.4	125	55.8
Abnormal	221	30	130	25.3	91	40.6
Hemoglobin (g/dL)
Normal	258	34.9	152	29.6	106	47.3
Abnormal	311	42.1	202	39.3	109	48.7
Creatinine (mg/dL)
Normal	685	93.1	469	91.3	216	96.4*
Abnormal	51	6.9	44	8.6	7	3.1
5 ALT U/L
Normal	451	61.1	276	53.7	175	78.1
Abnormal	100	13.6	61	11.9	39	17.4

^*p <0.05 comparing trial to non trial participants;

^**p≤0.001 comparing trial to non trial participants

¹MSM=Men who have sex with Men;

²Public insurance= Medicaid/Medicare;

³ID= University of North Carolina Infectious Disease;

⁴ANC=Absolute Neutrophil Count

⁵ALT=Alanine aminotransferase